2024-05-09 19:32:08 ET
Collegium Pharmaceutical, Inc. (COLL)
Q1 2024 Results Conference Call
May 09, 2024 04:30 PM ET
Company Participants
Christopher James - Vice President of Investor Relations
Joe Ciaffoni - Chief Executive Officer
Colleen Tupper - Chief Financial Officer
Scott Dreyer - Chief Commercial Officer
Mike Heffernan - Chairman
Conference Call Participants
David Amsellem - Piper Sandler
Les Sulewski - Truist Securities
Oren Livnat - H.C. Wainwright
Presentation
Operator
Greetings. And welcome to the Collegium Pharmaceutical First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation [Operator Instructions]. Please note that this conference call is being recorded.
I will now turn the call over to Christopher James, Vice President of Investor Relations at Collegium. Thank you. You may begin....
Read the full article on Seeking Alpha
For further details see:
Collegium Pharmaceutical, Inc. (COLL) Q1 2024 Earnings Call Transcript